Dmais Pharmaceuticals Private Limited - Company Profile

It is a trading private limited company based in New Delhi, Delhi, India, established in 2009.
2009 New Delhi, Delhi, India Struck Off
Last Updated:
About Dmais Pharmaceuticals Private Limited

Dmais Pharmaceuticals Private Limited, a struck off private limited company, was established on 02 February 2009 in New Delhi, Delhi, India. Engaging in retailers within the trading sector, it holds CIN: U85190DL2009PTC187161. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Meera Kumari Baranwal (Director), Arbind Kumar (Director), Tripurari Baranwal (Director). Past directors included Satish Kumar. Its latest AGM occurred on 30 September 2015, with the balance sheet filed on 31 March 2015. It is based at 39.Iind Floor,Mohammadpur Near Bikaji Cama Place, New Delhi, Delhi, 110066.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85190DL2009PTC187161

  • Registration Number

    187161

  • Incorporation Date

    02 February 2009

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 17 Year, 1 Month
  • Last Filing with ROC 31 Mar 2015
Company report

Dmais Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dmais Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Dmais Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Meera Kumari Baranwal Director 02 Feb 2009 Current
Arbind Kumar Director 02 Feb 2009 Current
Tripurari Baranwal Director 21 Feb 2011 Current
Dinesh Kumar Baranwal Director 21 Feb 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 21 Feb 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dmais Pharmaceuticals.

Enhance accessibility to Dmais Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Dmais Pharmaceuticals revenue growth over time
Dmais Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dmais Pharmaceuticals?

Unlock access to Dmais Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Dmais Pharmaceuticals?

Unlock and access historical data on people associated with Dmais Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dmais Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dmais Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dmais Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Dmais Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records. was documented.

  • Balance Sheet

    Dmais Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Progress on Tripurari Baranwal was appointed as a Director was appointed as a Director on 21 Feb 2011 & has been associated with this company since 15 years 18 days . was documented.

  • Director Appointment

    Dinesh Kumar Baranwal was appointed as a Director was appointed as a Director on 21 Feb 2011 & has been associated with this company since 15 years 18 days . was recorded as a recent event.

  • Director Appointment

    Progress on Meera Kumari Baranwal was appointed as a Director was appointed as a Director on 02 Feb 2009 & has been associated with this company since 17 years 1 month . was documented.

  • Director Appointment

    Progress on Arbind Kumar was appointed as a Director was appointed as a Director on 02 Feb 2009 & has been associated with this company since 17 years 1 month . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dmais Pharmaceuticals Private Limited?

The CIN of Dmais Pharmaceuticals Private Limited is U85190DL2009PTC187161.

Where is Dmais Pharmaceuticals Private Limited headquartered?

Dmais Pharmaceuticals Private Limited is headquartered at 39.Iind Floor,Mohammadpur Near Bikaji Cama Place, New Delhi, Delhi, 110066.

When was Dmais Pharmaceuticals Private Limited incorporated?

Dmais Pharmaceuticals Private Limited was incorporated on 02 February 2009.

Who are the current directors of Dmais Pharmaceuticals Private Limited?

The current directors of Dmais Pharmaceuticals Private Limited are

What is the primary industry of Dmais Pharmaceuticals Private Limited?

The primary industry of Dmais Pharmaceuticals Private Limited is Trading.

Is Dmais Pharmaceuticals Private Limited a listed company?

Dmais Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Dmais Pharmaceuticals Private Limited?

The authorized capital of Dmais Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available